Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in ST Elevation Myocardial Infarctions
NCT03022877Withdrawn
- Sponsor
- RWTH Aachen University
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
Randomised trial of levosimendan in myocardial infarction (MI) (3 arms), sponsored by RWTH Aachen University. Primary endpoint: Left ventricular end-diastolic volume index at 12 months. Planned start Jun 2017; status: withdrawn.
02
Drugs
levosimendan
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03022877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03022877.